StockData
Fractyl Health, Inc. logo

Fractyl Health, Inc. (GUTS) stock

GUTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.96−0.12 (-11.55%)

Close on Nov 19, 2026Market cap $152.07MP/E –Yield –

Fractyl Health free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Fractyl Health's free cash flow for the twelve months ending Dec 31, 2025 was -$90.89M. For fiscal 2025 it was -$90.89M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$90.89M–
FY2024Dec 31, 2024-$67.29M–
FY2023Dec 31, 2023-$43.18M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$21.34M–
Q3 FY2025Sep 30, 2025-$22.72M–
Q2 FY2025Jun 30, 2025-$21.30M–
Q1 FY2025Mar 31, 2025-$25.53M–
Q4 FY2024Dec 31, 2024-$17.27M–
Q3 FY2024Sep 30, 2024-$18.25M–
Q2 FY2024Jun 30, 2024-$19.00M–
Q1 FY2024Mar 31, 2024-$12.77M–
Q4 FY2023Dec 31, 2023-$10.74M–
Q3 FY2023Sep 30, 2023-$11.17M–
Q2 FY2023Jun 30, 2023-$11.71M–
Q1 FY2023Mar 31, 2023-$9.57M–

More Fractyl Health figures

See a number that looks wrong?